- Home
- CC vs SRPT Comparison
CC vs SRPT Comparison
Compare CC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- SRPT
- Stock Information
- Founded
- CC 2014
- SRPT 1980
- Country
- CC United States
- SRPT United States
- Employees
- CC N/A
- SRPT N/A
- Industry
- CC Major Chemicals
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- CC Industrials
- SRPT Health Care
- Exchange
- CC Nasdaq
- SRPT Nasdaq
- Market Cap
- CC 2.3B
- SRPT 1.9B
- IPO Year
- CC N/A
- SRPT 1997
- Fundamental
- Price
- CC $13.39
- SRPT $24.01
- Analyst Decision
- CC Buy
- SRPT Hold
- Analyst Count
- CC 8
- SRPT 30
- Target Price
- CC $18.00
- SRPT $36.59
- AVG Volume (30 Days)
- CC 2.8M
- SRPT 4.6M
- Earning Date
- CC 11-06-2025
- SRPT 11-03-2025
- Dividend Yield
- CC 2.61%
- SRPT N/A
- EPS Growth
- CC N/A
- SRPT N/A
- EPS
- CC N/A
- SRPT N/A
- Revenue
- CC $5,850,000,000.00
- SRPT $2,481,531,000.00
- Revenue This Year
- CC $4.88
- SRPT $9.68
- Revenue Next Year
- CC $0.21
- SRPT N/A
- P/E Ratio
- CC N/A
- SRPT N/A
- Revenue Growth
- CC 0.62
- SRPT 64.89
- 52 Week Low
- CC $9.13
- SRPT $10.42
- 52 Week High
- CC $22.38
- SRPT $138.81
- Technical
- Relative Strength Index (RSI)
- CC 41.88
- SRPT 60.36
- Support Level
- CC $12.69
- SRPT $22.80
- Resistance Level
- CC $14.28
- SRPT $24.38
- Average True Range (ATR)
- CC 0.64
- SRPT 1.09
- MACD
- CC -0.00
- SRPT -0.02
- Stochastic Oscillator
- CC 34.15
- SRPT 86.78
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.